AzTrials
AzTrials

Knee OsteoarthritisSFCLNCT00912106

Analyzing Composition and Lubrication Properties of Synovial Fluid

An observational study of Knee Osteoarthritis and HA Injection, run by Far Eastern Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To analyze the relationship between composition of synovial fluid and its lubrication properties Read more about this study

Who is it for?
Any age
What is being tested?
Synovial fluid composition and lubrication analysis
Type of treatment
Injection or infusion
How many people
55 participants
Where
1 siteTaiwan
Study dates
Apr 2008to Jun 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients who are going to receive HA injection of one or two knees

Who may be able to join

  • Patients who are going to receive HA injection of one or two knees

Who cannot join

  • Patients whose quantity of synovial fluid is not enough to be drawn

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Far Eastern Memorial Hospital

    Pan-Ciao, Taipei, 22050

Other trials in Taiwan

About this study

Official title: Boundary Lubrication of Synovial Fluid Molecules and Its Effect on the Surrounding Cells and Tissues

To analyze the relationship between composition of synovial fluid and its lubrication properties

Read the detailed description

Patients suffering from serious arthritis may receive the artificial joint replacement surgery. Comparing to the articulation of articular cartilage, the artificial joint undergo a boundary lubrication in which a thin layer of synovial fluid molecules is formed between the artificial joint materials. Therefore a larger wear rate is observed in the artificial joint system. Researchers have devoted themselves to modifying the artificial joint materials in order to reduce the wear phenomena. We first propose that modification the lubrication by adding effective lubricating molecules may help to reduce the wear of artificial joint. However, there still lacks fundamentally understanding of the artificial joint lubrication mechanism under synovial fluid. Hence, we plan to investigate the boundary lubrication mechanism of synovial molecules, such as albumin, globulin, hyaluronic acid, and lipid in the first year. We would like to obtain the adsorption behaviors of the single molecules as well as multiple molecules on the surfaces of artificial joint materials by experiments. Molecular dynamics simulation will also be performed to gain the knowledge of adsorption energy and possible conformation change of the molecules. In the second year, the tribological heat and mechanical effects on the synovial molecules will be studied. The analysis platform will be established to perform the composition and properties measurement of the synovial molecules. In the third year, we will further discuss the effect of the synovial molecules transformation on the surrounding cells and tissues. Their influences on the tribological and biochemical behaviors will be investigated.

Being tested
Synovial fluid composition and lubrication analysis
Keywords
osteoarthritis, HA, synovial fluid, lubrication
Medical subject headings
Osteoarthritis, Knee, Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Synovial fluid composition and lubrication analysisOther

    Before HA injection, synovial fluid must be drawn to increase treatment effectiveness. The drawn synovial fluid was then analyzed in the lab. There was no influence for patients enrolled because the drawn synovial fluid would usually be discarded.

Study groups in NCT00912106
Study groupRoleWhat they receive
HA injectionPatients with osteoarthritis of knee. They are going to received HA injection 1 vial per week for 5 weeks.
Receives: Other: Synovial fluid composition and lubrication analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Synovial fluid HA and albumin concentration; synovial fluid lubrication

    Measured: 1 wk, 2 wk, 3 wk, 4 wk, 5 wk

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2009 (estimated)
  2. Study startApr 2008
  3. Primary completionDec 2008
  4. Study completionJun 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00912106
Sponsor's protocol ID
96024
Other IDs
NSC-96-
Acronym
SFCL
Status last verified
Jun 2009
First submitted
2 Jun 2009
Last updated
3 Jun 2009
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Knee Osteoarthritis and HA Injection, run by Far Eastern Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jun 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Synovial fluid HA and albumin concentration; synovial fluid lubrication (time frame: 1 wk, 2 wk, 3 wk, 4 wk, 5 wk). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in